跳至主要内容
临床试验/NCT05841368
NCT05841368尚未招募不适用

DELIRIUM SCREENING, INCIDENCE AND MANAGEMENT OBSERVATIONAL STUDY IN 2024 - THE CZECH REPUBLIC

Brno University Hospital1 个研究点 分布在 1 个国家目标入组 2,000 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
2,000
试验地点
1
主要终点
Delirium prevalence

研究概览

简要总结

Delirium in intensive care unit (ICU) settings is a frequent complication with reported prevalence of 31%. Recent data has revealed the connection between delirium and increased 30days mortality after hospital release and the higher incidence of readmission to emergency. Despite the high prevalence and well described validation methods for screening, the precise incidence remains unclear due to insufficient screening in ICU settings. The incidence of delirium in Czech Republic remains undescribed, beside data reported from neurointensive care patients and single-center general critically ill patients data.

详细描述

All patients fulfilling inclusion criteria in intensive care settings in involved ICUs in Czech Republic will be included into the study. Data will be recorded for 1 consequent month. Basic demography will be evaluated. In each patient standard delirium screening based on the institutional ICU rules will be performed. If no screening method were set,Confusion Assessment Method - CAM-ICU for adult and pediatric Confusion Assessment Method -pCAM-ICU for pediatric patients would be used together with delirium management, restrain procedures, sedative/neuroleptics administration, 28-days mortality. All data will be recorded into to predefined eCRF.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients in ICU settings
  • in defined time interval of the study

排除标准

  • duration of ICU stay shorter than 24 hours

结局指标

主要结局

Delirium prevalence

时间窗: during 30 days after study initiation in selected ICU

Delirium prevalence by CAM-ICU and pCAM-ICU will be screened in defined time interval

次要结局

  • Delirium management(during 30 days after study initiation in selected ICU)
  • 90-days mortality(after patient inclusion into the study)
  • Inhospital mortality(during 30 days after study initiation in selected ICU)
  • 28-days mortality(after patient inclusion into the study)

研究者

发起方
Brno University Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Petr Štourač, MD

Clinical Professor

Brno University Hospital

研究点 (1)

Loading locations...

相似试验